InspireMD (STU:II2) Cyclically Adjusted FCF per Share: €-256.97 (As of Mar. 2026)


STU:II2 InspireMD Inc STU:II2
42 GF Score
Price €0.60
GF Value €1.50
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Cyclically Adjusted FCF per Share?

InspireMD STU:II2 +2.56% 42 Cyclically Adjusted FCF per Share is €-256.97 as of Mar. 2026. GuruFocus rates STU:II2 with a GF Score™ of 42/100 and a GF Value™ of €1.50 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

InspireMD's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.129. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-256.97 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of InspireMD was 29.50% per year. The lowest was 11.40% per year. And the median was 15.00% per year.

As of today (2026-07-06), InspireMD's current stock price is €0.60. InspireMD's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-256.97. InspireMD's Cyclically Adjusted Price-to-FCF of today is .


InspireMD  (STU:II2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


InspireMD Cyclically Adjusted FCF per Share Related Terms


InspireMD Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for InspireMD's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD Cyclically Adjusted FCF per Share Chart

InspireMD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,017.69 -417.09 -321.88 -325.79 -270.67

InspireMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -302.12 -277.86 -268.48 -270.67 -256.97

STU:II2 vs TELA, BDMD, PAVM: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, InspireMD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where InspireMD's Cyclically Adjusted Price-to-FCF falls into.


STU:II2
42GF Score
InspireMD Inc STU:II2
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InspireMD Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InspireMD's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.129/330.2130*330.2130
=-0.129

Current CPI (Mar. 2026) = 330.2130.

InspireMD Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 -759.000 246.524 -1,016.662
201803 -481.667 249.554 -637.348
201806 -211.222 251.989 -276.791
201809 -29.056 252.439 -38.008
201812 -31.725 251.233 -41.698
201903 -56.107 254.202 -72.884
201906 -28.826 256.143 -37.162
201909 -15.900 256.759 -20.449
201912 -5.590 256.974 -7.183
202003 -6.916 258.115 -8.848
202006 -1.559 257.797 -1.997
202009 -1.111 260.280 -1.410
202012 -0.551 260.474 -0.699
202103 -0.503 264.877 -0.627
202106 -0.278 271.696 -0.338
202109 -0.472 274.310 -0.568
202112 -0.341 278.802 -0.404
202203 -0.485 287.504 -0.557
202206 -0.391 296.311 -0.436
202209 -0.687 296.808 -0.764
202212 -0.387 296.797 -0.431
202303 -0.560 301.836 -0.613
202306 -0.148 305.109 -0.160
202309 -0.114 307.789 -0.122
202312 -0.120 306.746 -0.129
202403 -0.141 312.332 -0.149
202406 -0.125 314.175 -0.131
202409 -0.114 315.301 -0.119
202412 -0.136 315.605 -0.142
202503 -0.169 319.799 -0.175
202506 -0.151 322.561 -0.155
202509 -0.104 324.800 -0.106
202512 -0.101 324.054 -0.103
202603 -0.129 330.213 -0.129

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-256.97 mean?
InspireMD (STU:II2) has a Cyclically Adjusted FCF per Share of €-256.97 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InspireMD and its competitors.
Is InspireMD's Cyclically Adjusted FCF per Share too high?
InspireMD's current Cyclically Adjusted FCF per Share is €-256.97. Overall, InspireMD has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InspireMD's Cyclically Adjusted FCF per Share compare to TELA and BDMD?
InspireMD's Cyclically Adjusted FCF per Share of €-256.97 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InspireMD and its competitors. InspireMD's current Cyclically Adjusted FCF per Share is €-256.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InspireMD stock overvalued right now?
Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.50, compared to a current price of €0.60 — trading 60% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-256.97. InspireMD's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For InspireMD (STU:II2), the current Cyclically Adjusted FCF per Share is €-256.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.60 is trading 60% below its estimated GF Value™ of €1.50. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

  • Cyclically Adjusted FCF per Share: €-256.97
  • GF Value™: €1.50 vs. price of €0.60 (60% below fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InspireMD Business Description

Other Exchanges NSPR:USA
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
42GF Score

Get the complete analysis for STU:II2

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.60
Price
€1.50
GF Value